SWOG clinical trial number
S1916

Feasibility of a Digital Medicine Program in Optimizing Opioid Pain Control in Cancer Patients

Open
Accrual
0%
Abbreviated Title
Digital Medicine for Opioid Pain Control
Status Notes
This is being distributed for IRB review only.
Activated
06/11/2019

Research committees

Cancer Care Delivery

Eligibility Criteria Expand/Collapse

Patients must have a diagnosis of metastatic cancer. Patients currently on oxycodone/acetaminophen are eligible as long as they are on the 5 mg/325 mg dose. Patients currently on another opiate, who have been prescribed or will be prescribed oxycodone/acetaminophen as an addition to their therapy are also eligible. Patients must have a worst pain score of at least 3 (on a scale of 0-10) on the Brief Pain Inventory (BPI)* within 3 days prior to registration and be deemed by their physician to require initiation, continuation, or uptitration of opioid therapy with oxycodone/acetaminophen 5mg/325mg.
Patients must be >/= 18 years of age; must complete baseline PROs prior to registration; must be able to read English, must be willing to participate in electronic data collection and just have an iPhone, Android phone, or tablet with cellular connectivity and must have successfully downloaded the Proteus Discover App. Patients must not have a known allergy to adhesive tape, hydrogel or conductive get or hydrocolloid; Women must not be pregnant or nursing. Patients of reproductive potential must have agreed to use an effective contraceptive method.

Other Clinical Trials

SWOG Clinical Trial Number
S1105
SWOG Clinical Trial Number
S1204

A Sero-Epidemiologic Survey and Cost-effectiveness Study of Screening for Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Among Newly Diagnosed Cancer Patients

Research Committee(s)
Cancer Care Delivery
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Leukemia
Lung Cancer
Lymphoma
Melanoma
Myeloma
Activated
08/29/2013
Closed
02/15/2017
Accrual
100%
Closed
SWOG Clinical Trial Number
S1417CD

Implementation of a Prospective Financial Impact Assessment Tool in Patients with Metastatic Colorectal Cancer

Research Committee(s)
Cancer Care Delivery
Gastrointestinal Cancer
Activated
04/15/2016
Closed
02/01/2019
Accrual
100%
Open